Engineer Oujan Ahani, CEO of Ako Sanat Tejarat Arya, in an interview with the Chemistry Darou magazine reporter, stated: This company specializes in the production of pharmaceutical packaging components and supplies. Ako Sanat Tejarat Arya started its activities with the production of flip-off vial caps and expanded its product portfolio. The company’s products are used in the pharmaceutical, cosmetic, hygiene, and food industries.
Oujan Ahani added: Ako Sanat, with consistent efforts to maintain quality and achieve its developmental goals, is establishing a new production facility in the Barkat Pharmaceutical Industrial Town. This factory, spanning 6000 square meters, is being developed based on global standards and equipped with the latest and most advanced production technologies.
The CEO of Ako Sanat Tejarat Arya emphasized the role of the government in fostering production in the country and said: In developed countries, government intervention in production is primarily supportive, whereas in Iran, it often acts as a barrier. It would be better for the government to remove obstacles as much as possible and act as a catalyst for production. Additionally, the government can facilitate production by offering low-interest loans to manufacturing companies and removing restrictive export regulations.
Oujan Ahani spoke about the objectives of Ako Sanat in the Pharmex Middle East 2021 international festival and said: As a leading company in the pharmaceutical packaging industry, it prefers to participate in all specialized events to connect with its professional audience. Through these events, it can provide information about its new products.
He continued: One of the objectives of Ako Sanat is to understand the needs of the pharmaceutical industry. Participating in events and interactions that take place are very effective in identifying these needs and are instrumental in expanding the company’s product portfolio. Additionally, these events provide a suitable platform for engaging with our target audience regarding any issues or defects in previous products. This also facilitates the annual customer satisfaction process, enabling us to improve quality by addressing raised concerns.
Oujan Ahani highlighted the company’s export objectives for 2021 and said: This also facilitates the annual customer satisfaction process, enabling us to improve quality by addressing raised concerns. With specific planning by this group, Ako Sanat will participate in exhibitions related to these countries. Clearly, the government can significantly influence exports in this industry by creating a supportive environment and offering necessary facilities and arrangements to participate in these exhibitions and showcase products.
He outlined the employment and production capacity development plans for Ako Sanat Tejarat Arya as follows: Currently, Ako Sanat, with approximately 100 staff members specializing in various areas of production, sales, administration, and human resources, is rapidly advancing and expanding. Within the next year, it plans to establish one of the most modern and advanced pharmaceutical packaging equipment factories in the Barkat Pharmaceutical Industrial Town.
The CEO of Ako Sanat Tejarat Arya considered the Pharmex 2021 festival as beneficial for the international position of Iran’s pharmaceutical industry and said: Certainly, holding events like Pharmex, due to high participation and specialization, provides a suitable platform for more interactions among pharmaceutical companies and their affiliates, thereby improving the quality of this industry domestically and internationally. The efforts of the organizers of events like Pharmex, particularly under the health protocols of the COVID-19 pandemic, are commendable.
Oujan Ahani concluded by emphasizing the high quality of the company’s products and said: Ako Sanat, with its high-quality products, an integrated management system, and the use of experienced management consultants, has succeeded in obtaining ISO 9001:2015 certification and (ISO 227116 GMP) from TUV AUSTRIA. This outstanding track record and reputation enabled Ako Sanat to participate in the production of domestic COVID-19 vaccines and collaborate with leading pharmaceutical companies.
You can view the interview transcript at the link below:
